title: Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
abstract: The gut bacterial microbiome, particularly its role in disease and inflammation, has gained international attention with the successful use of fecal microbiota transplantation (FMT) in the treatment of Clostridium difficile infection. This success has led to studies exploring the role of FMT in other conditions, including inflammatory bowel disease (IBD). Both Crohn's disease and ulcerative colitis are chronic inflammatory conditions of the gastrointestinal system that have multifactorial etiologies. A shift in gut microbial composition in genetically susceptible individuals, an altered immune system, and environmental factors are all hypothesized to have a role in the pathogenesis of IBD. While numerous case reports and cohort studies have described the use of FMT in patients with IBD over the last 2 decades, the development of new sequencing techniques and results from 2 recent randomized, controlled trials have allowed for a better understanding of the relationship between the microbiome and the human host. However, despite these efforts, knowledge remains limited and the role of FMT in the management of IBD remains uncertain. Further investigation is necessary before FMT joins the current armamentarium of treatment options in clinical practice.
authors: Dr Lopez is a gastroenterology fellow and Dr Grinspan is an assistant professor of medicine at Icahn School of Medicine at Mount Sinai in New York, New York.
authors: Joanna
authors: J
authors: Lopez
authors: Dr Lopez is a gastroenterology fellow and Dr Grinspan is an assistant professor of medicine at Icahn School of Medicine at Mount Sinai in New York, New York.
authors: Ari
authors: A
authors: Grinspan
keywords: Crohn’s disease; Fecal microbiota transplantation; inflammatory bowel disease; ulcerative colitis